1. Intended Use

1.1       This website (www.bsacsurv.org) presents data collected specifically for the BSAC Resistance Surveillance Programme. It is intended for use by professionals and students in microbiology, epidemiology, and other scientific and healthcare disciplines.

1.2       Information provided on this site must not be used for the purposes of individual medical advice.

  1. Ownership of the BSAC Resistance Surveillance Programme

2.1       The Resistance Surveillance Programme database, including copyright and technical functionality, belongs to the BSAC. No part of the database or its functionality can be reproduced without the express written permission of the BSAC.

2.2       All data present on the database is anonymous and does not contain any patient identifiable information. The anonymised aggregated data submitted to the database belongs to BSAC with due acknowledgement given to all participating laboratories.

  1. Use of information, including data, from this website

3.1       To mitigate the risk of making valid or meaningless analyses of data contained within this site, you must not represent that your analyses or interpretations have the authority of the BSAC.

3.2       If you use information from this site you must acknowledge the BSAC in the following manner: ‘BSAC Bacteraemia Resistance Surveillance Programme’ or ‘BSAC Respiratory Resistance Surveillance Programme’ as appropriate, plus the website address www.bsacsurv.org and the date you accessed the data.

    1. The primary journal articles describing the methodology of the two surveillance programmes are:
  • Reynolds, R., Hope, R., Williams, L., on behalf of the BSAC Working Parties on Resistance Surveillance. Survey, laboratory, and statistical methods for the BSAC Resistance Surveillance Programmes. Journal of Antimicrobial Chemotherapy, 2008. 62(Suppl 2): p. ii15 – ii28
  • Reynolds, R., Lambert, P. and Burton, P. on behalf of the BSAC Working Parties on Resistance Surveillance. Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover. Journal of Antimicrobial Chemotherapy, 2008. 62(Suppl 2): p. ii29 – ii39.
    1. Earlier descriptions of the programmes were published as:
  • Reynolds, R., Shackcloth, J., Felmingham, D. et al. (2003). Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. Journal of Antimicrobial Chemotherapy 52, 931-943
  • Reynolds, R., Potz, N., Colman, M. et al. (2004). Antimicrobial Susceptibility of the Pathogens of Bacteraemia in the UK and Ireland 2001 – 2002: the BSAC Bacteraemia Resistance Surveillance Programme. Journal of Antimicrobial Chemotherapy 53 , 1018-1032.
  1. Publication of Data

4.1       Any downloaded information from the database should not be altered and its source acknowledged.

4.2       Any individual or individuals wishing to undertake research; publish or present data from the database must apply to do so in writing by emailing RS@bsac.org.uk in the first instance. Requests will be dealt with within 10 working days and the decision (authorisation to proceed or decision to decline with reasons) will be returned to applicants by email.

4.3       Acceptance of these the terms and conditions includes acceptance that data from the Resistance Surveillance Programme can be used for research, publication and presentation of such data.

4.4       Once authorised, the data source must be acknowledged as the BSAC Resistance Surveillance Programme. If publications are not being submitted for publication in a peer review journal or other peer review publication, a copy of the manuscript, plus details of how and where publication is proposed must be submitted to the BSAC Publications Committee for approval. This can be done by submitting a request in writing to the Chair of the BSAC Publications Committee at the registered address (available at www.bsac.org.uk).

5          Document Reference

Document Author: C. Horner

Version: 2.0

Date: July 2017

Date of Review: July 2018